Acquisition reinforces Qualia’s strategy and opens new opportunities for growth in Greece and abroad.
Children visited our premises to decorate the Christmas tree and create a wall full of Joy. Merry Christmas & Happy New Year.
Qualia Pharma and Bionature signed a collaboration agreement on the clinical development of a novel class of molecules (called Microneurotrophins) for treating Alzheimer’s disease.
The pharmacy trade magazine “Anavathmisi Pharmakion” hosts a personal interview from the CEO of Qualia pharma, Mr. Fotis Sakellaridis.
It was a great pleasure to welcome to our premises Mr Geert Wirtz, CEO BioMinerals NV and Richard Passwater Jr, BioMinerals USA.
Today, under an official notary process, we are pleased to announce the names of the 3 winners of our pharmacy contest.
European Commission announced today, that the project VALUMAG will be financed under the program Horizon 2020 with the amount of 4.7 million €.
Today, a big pharmacy contest has been launched by Qualia Consumer Health.
BioSil, one of the most famous dietary supplements worldwide, has been launched in Greece by Qualia Consumer Health.
Qualia Consumer Health announces the launch of a new food supplement, Revert, in the Greek market.
Recolin is a novel dietary supplement especially designed to enhance memory, improve focus & attention and increase mental energy.
The Greek Dementia Association, organized with great success and high turnout of scientists, the 4th Conference "Master Classes in Dementia 2016".
©2018 qualiapharma.com, All rights reserved